To date, ligament and tendon replacements largely utilize autograft/allograft transplantation, although the use of tissue engineered materials remain a promising solution [10]. The development of an engineered solution may depend on the choice of scaffold materials with optimal fiber alignment. Type I collagen is an abundant extracellular matrix component in musculoskeletal tissues. The controlled alignment of type I collagen for tissue engineering and regenerative medicine applications enables the fabrication of unique scaffolds that emulate the ultrastructure of their native counterparts. Moreover, the alignment of type I collagen has become a common technique to manipulate mechanical properties of tissue constructs and the biological response of embedded cells [1,2]. It is additionally important to develop noninvasive methods to align collagen structures while maintaining inherent structural integrity and biological activity.

This content is only available via PDF.
You do not currently have access to this content.